Entera Bio Ltd.（ENTX）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · ENTX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$0.04M	$0.18M	$0.00M	$0.13M	$0.57M
Cost of Revenue	$0.04M	$0.17M	$0.06M	$0.17M	$0.37M
Gross Profit	$0.00M	$0.01M	($0.06M)	($0.03M)	$0.20M
Gross Margin %(computed)	0.00%	4.97%	—	-23.13%	34.68%
Operating Expenses
R&D Expenses	$6.00M	$4.50M	$4.45M	$5.78M	$6.77M
G&A Expenses	$5.53M	$5.09M	$0.00M	$0.00M	$5.69M
Total Operating Expenses	$11.53M	$9.59M	$8.88M	$13.04M	$12.41M
Operating Income	($11.53M)	($9.59M)	($8.94M)	($13.07M)	($12.22M)
Operating Margin %(computed)	—	—	—	—	—
Interest Income	$0.00M	$0.06M	$0.03M	$0.08M	$0.00M
Interest Expense	$0.00M	$0.00M	$0.00M	$0.00M	$0.03M
Income Before Tax	($11.44M)	($9.53M)	($8.86M)	($12.93M)	($12.25M)
Income Tax Expense	$0.00M	$0.01M	$0.03M	$0.14M	($0.06M)
Net Income	($11.44M)	($9.54M)	($8.89M)	($13.07M)	($12.19M)
Net Margin %(computed)	—	—	—	—	—
Per Share & EBITDA
EPS (Basic)	$-0.25	$-0.25	$-0.31	$-0.45	$-0.47
Wtd Avg Shares	46.19M	37.65M	29.01M	28.81M	26.13M
EBITDA	($11.50M)	($9.54M)	($8.80M)	($12.87M)	($12.16M)
EBITDA Margin %(computed)	—	—	—	—	—